Becton, Dickinson and Co. | BDX - Selling And Administration Expenses

Stock Price
201.63
Daily Change
-1.85 -0.91%
Monthly
1.34%
Yearly
-18.57%
Q1 Forecast
197.21

Becton, Dickinson and Co. reported $1.37B in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Agilent USD 428M 37M Sep/2025
Align Technology USD 417.8M 30.89M Sep/2025
Avanos Medical USD 77.6M 5.9M Sep/2025
Baxter International USD 708M 10M Sep/2025
Becton, Dickinson and Co. USD 1.37B 46M Sep/2025
Bio-Rad Laboratories USD 207.7M 14.2M Jun/2025
Boston Scientific USD 1.74B 25M Sep/2025
Cooper Companies USD 419.2M 12M Sep/2025
Danaher USD 2.03B 35M Dec/2025
Dentsply International USD 355M 21M Sep/2025
Dexcom USD 331.4M 3.4M Sep/2025
Edwards Lifesciences USD 514.6M 12.6M Sep/2025
Exact Sciences USD 491.64M 35.94M Sep/2025
Globus Medical USD 313.6M 9.98M Sep/2025
Hologic USD 2.5B 2.24B Dec/2025
Insulet USD 315.2M 61.9M Sep/2025
Integra LifeSciences USD 169.05M 10.84M Sep/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
J&J USD 6.75B 831M Dec/2025
Masimo USD 116.4M 20.5M Sep/2025
Medtronic 2.97B 159M Sep/2025
Solventum Corp USD 744M 28M Sep/2025
Stryker USD 2.14B 150M Dec/2025
Tandem Diabetes Care USD 94.52M 1.47M Sep/2025
Teleflex USD 281.76M 66.68M Sep/2025
Terumo JPY 97.88B 5.9B Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Zimmer Biomet Holdings USD 811.4M 3.4M Sep/2025